Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to evaluate the antiviral efficacy (sustained virologic response [SVR]; defined as undetectable HCV RNA 24 weeks following treatment cessation) of 16 and 24 weeks of response guided duration of therapy with GS-9190, GS-9256, ribavirin (RBV), and peginterferon alfa 2a (PEG).
Critère d'inclusion
- Chronic hepatitis C virus infection